Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Venrock Healthcare Capital Partners III, L.P.'s stake in Cytomx Therapeutics, Inc. fell to 4.60% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Venrock Healthcare Capital Partners III, L.P.'s stake in Cytomx Therapeutics, Inc. fell to 4.60%, 9,982,124 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.60%
- Shares
- 9,982,124
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 4.60% | 9,982,124 |
| VHCP Co-Investment Holdings III, LLC | 4.60% | 9,982,124 |
| Venrock Healthcare Capital Partners EG, L.P. | 4.60% | 9,982,124 |
| VHCP Management III, LLC | 4.60% | 9,982,124 |
| VHCP Management EG, LLC | 4.60% | 9,982,124 |
| Nimish Shah | 4.60% | 9,982,124 |
| Bong Y. Koh | 4.60% | 9,982,124 |
Source
Related
- Cytomx Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Nov 14, 2025
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · May 20, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026